Cáncer de vesícula biliar

+ -Text Size

Otros recursos y referencias TEMAS

Referencias: Guía detallada del cáncer de vesícula biliar

Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010.

American Cancer Society. Cancer Facts & Figures 2013. Atlanta, Ga: American Cancer Society; 2013.

American Joint Committee on Cancer. Gallbladder. In: AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010: 211–214.

Bartlett DL, Ramanathan RK, Ben-Josef E. Cancer of the biliary tree. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2008: 1156–1186.

Dixon E, Vollmer CM, Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer. Ann Surgery. 2005;241:385–394.

Fong Y, Wagman L, Gonen M, et al. Evidence-based gallbladder cancer staging: Changing cancer staging by analysis of data from the National Cancer Database. Ann Surg. 2006;243:767–771.

Gruenberger B, Schueller J, Heubrandtner U, et al. Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: A phase 2 study. Lancet Oncol. 2010 Dec;11(12):1142-8. Epub 2010 Nov 9.

Lazcano-Ponce EC, Miquesl JF, Munoz N, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51:349–364.

Misra S, Chaturvedi A, Misra NC, et al. Carcinoma of the gallbladder. Lancet Oncology. 2003;4:167–176.

National Cancer Institute. Physician Data Query (PDQ). Gallbladder Cancer Treatment. 1/20/2012. Accessed at www.cancer.gov/cancertopics/pdq/treatment/gallbladder/HealthProfessional on April 3, 2012.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers. V.2.2012. Accessed at www.nccn.org on April 4, 2012.

Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273-1281.

Weber S, Jarnagin W, Duffy A, O'Reilly EM, Abou-Alfa GK, Blumgart L. Liver and bile duct cancer. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE. Kastan MB, McKenna WG, eds. Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier; 2008: 1569–1594.

Wistuba II, Gazdar AF. Gallbladder cancer: Lessons from a rare tumor. Nature Reviews Cancer. 2004;4:695–706.


Fecha de última actualización: 05/24/2012
Fecha de último cambio o revisión: 01/18/2013